Langerhans cell histiocytosis screening: Difference between revisions
No edit summary |
No edit summary |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Langerhans cell histiocytosis}} | {{Langerhans cell histiocytosis}} | ||
{{CMG}} {{AE}} {{HL}} | |||
==Overview== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for Langerhans cell histiocytosis. | |||
==Screening== | |||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for Langerhans cell histiocytosis.<ref name="US">Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016</ref> | |||
==References== | ==References== | ||
{{Reflist| | {{Reflist|1}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
| Line 12: | Line 15: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Dermatology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 18:55, 25 March 2019
|
Langerhans cell histiocytosis Microchapters |
|
Differentiating Langerhans cell histiocytosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Langerhans cell histiocytosis screening On the Web |
|
American Roentgen Ray Society Images of Langerhans cell histiocytosis screening |
|
Directions to Hospitals Treating Langerhans cell histiocytosis |
|
Risk calculators and risk factors for Langerhans cell histiocytosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Langerhans cell histiocytosis.[1]
References
- ↑ Recommendations. U.S Preventive Task Force (2015) http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=Langerhans+cell+histiocytosis+ Accessed on February, 4 2016